Clinical options for the reduction of elevated intraocular pressure.

Ophthalmology and eye diseases Pub Date : 2012-04-30 Print Date: 2012-01-01 DOI:10.4137/OED.S4909
Laura Crawley, Sohaib M Zamir, Maria F Cordeiro, Li Guo
{"title":"Clinical options for the reduction of elevated intraocular pressure.","authors":"Laura Crawley, Sohaib M Zamir, Maria F Cordeiro, Li Guo","doi":"10.4137/OED.S4909","DOIUrl":null,"url":null,"abstract":"<p><p>Elevated IOP in clinical practice is usually seen in glaucoma or ocular hypertension. Glaucoma affects 60 million people worldwide and 8.4 million are bilaterally blind from this chronic disease.1 Options for reducing IOP rely on pharmacological agents, laser treatments and surgery which may be penetrating or non-penetrating. The last twenty years has seen significant changes in all of these strategies. This review aims to cover these clinical options and introduce some of the new technologies currently in development for the clinical lowering of IOP.</p>","PeriodicalId":74362,"journal":{"name":"Ophthalmology and eye diseases","volume":"4 ","pages":"43-64"},"PeriodicalIF":0.0000,"publicationDate":"2012-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3619493/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Ophthalmology and eye diseases","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4137/OED.S4909","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2012/1/1 0:00:00","PubModel":"Print","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Elevated IOP in clinical practice is usually seen in glaucoma or ocular hypertension. Glaucoma affects 60 million people worldwide and 8.4 million are bilaterally blind from this chronic disease.1 Options for reducing IOP rely on pharmacological agents, laser treatments and surgery which may be penetrating or non-penetrating. The last twenty years has seen significant changes in all of these strategies. This review aims to cover these clinical options and introduce some of the new technologies currently in development for the clinical lowering of IOP.

Abstract Image

降低眼压升高的临床方案。
在临床实践中,眼压升高通常见于青光眼或眼压过高。全世界有 6000 万人患有青光眼,其中 840 万人因这种慢性疾病而双目失明。1 降低眼压的方法主要有药物治疗、激光治疗和手术治疗,其中手术治疗可以是穿透性的,也可以是非穿透性的。在过去的二十年中,所有这些策略都发生了重大变化。本综述旨在介绍这些临床选择,并介绍一些目前正在开发的用于临床降低眼压的新技术。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
审稿时长
8 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信